The antibacterial drug Tygacil carries a higher risk of death than other drugs of its kind, an article by Reuters reports.
The U.S. Food and Drug Administration issued a safety announcement on September 27, 2013 approving a new Black Box Warning, the strongest warning that can be given to a drug, as well as updated Warnings and Precautions and Adverse Reactions portions of the drug label.
The FDA states on their ...
continue reading...
In June, 2010, the FDA announced that it would continue to review potential risks and safety concerns of the antihypertensive medication Benicar after studies revealed serious cardiovascular risks. Now, three years later, an article on DrugInjuryWatch.com questions when the findings will be available to patients and doctors.
Two clinical trials highlighted a significantly higher rate of cardiovascular-related death in patients taking Benicar with Type 2 diabetes. Manufactured by Daiichi Sankyo, Benicar is prescribed to diminish hypertension ...
continue reading...
The attorneys at Lopez McHugh are actively representing women who claim to have been injured by defective transvaginal mesh products. As a result, we have been keeping a close eye on the developments of the Multidistrict Litigation (known as MDL) in the Southern District of West Virginia.
In the MDL, the court recently issued a pretrial order that has selected four cases to serve as bellwether trials. The first bellwether trial is set ...
continue reading...
Last week, the U.S. Food and Drug Administration announced a voluntary recall of Nova Max Blood Glucose Test Strips that may report a false, abnormally high blood glucose result.
The FDA stated in a news release that “under certain conditions, a false, abnormally high blood glucose level could result in an insulin dosing error, requiring the user to seek immediate medical attention.”
It has been reported that nearly 62 million strips may be affected by this recall. ...
continue reading...
According to a CBS report, the Food and Drug Administration is warning consumers about the potential for the rare skin complications Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) after taking acetaminophen, one of the most widely used medicines in the United States.
According to the FDA, SJS and TEN are extremely rare but can be deadly. These conditions can cause blisters, serious rashes, reddening of the skin and the detachment of the upper surface of ...
continue reading...
The U.S. Food and Drug Administration is investigating whether olmesartan-based blood pressure drugs Benicar, Azor, and Tribenzor increase the risk of enteropathy.
Benicar, known as olmesartan, an angiotensin II receptor blocker, was approved by the FDA on April 25, 2002, to treat high blood pressure. It is manufactured under the brand names Benicar, Benicar HCT, Azor, and Tribenzor.
Recently, the FDA issued a safety warning that Benicar, Azor, and Tribenzor can ...
continue reading...
